Related Experiment Video

Updated: Jun 8, 2026

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression
08:58

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on: April 18, 2025

Antibiotic hypersensitivity in CF: drug-induced life-threatening hemolytic anemia in a pediatric patient

Alma Chavez1, Amir Mian, Amy M Scurlock

  • 1Pulmonary Department, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, United States.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|September 14, 2010
PubMed

Insights

Antibiotic hypersensitivity is a growing concern in cystic fibrosis (CF) patients. This case highlights severe piperacillin-induced hemolytic anemia in a pediatric CF patient, emphasizing the need for careful management of drug reactions.

Area of Science:

  • Immunology
  • Pharmacology
  • Pediatrics

Background:

  • Adverse antibiotic reactions are an increasing concern in cystic fibrosis (CF) care.
  • Patients with CF often have comorbidities and a history of drug reactions, complicating treatment.
  • Antibiotic hypersensitivity in CF requires a deeper understanding of its frequency, pathogenesis, and risk factors.

Observation:

  • A pediatric patient with CF and multiple comorbidities experienced life-threatening piperacillin-induced immune hemolytic anemia.
  • This severe adverse drug reaction underscores the potential risks associated with antibiotic therapy in this population.

Findings:

  • Drug-induced immune hemolytic anemia (DIIHA) is a critical consideration in CF patients.
  • Piperacillin can trigger severe immune-mediated hemolytic anemia.
  • Understanding risk factors and pathogenesis is crucial for prevention and management.

Implications:

  • This case highlights the importance of recognizing and managing antibiotic hypersensitivity in CF.
  • A proposed algorithm can guide the treatment of drug-induced hypersensitivity reactions in CF patients.
  • Improved management strategies are needed to ensure safe and effective antibiotic use in CF.

More Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

Related Concept Videos

Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...